ClinicalTrialsFinder

Gastroenteropancreatico Tumors Clinical Trials in Bethesda, Maryland

1 recruitingBethesda, Maryland

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)

Neuroendocrine TumorsNeuroendocrine NeoplasmsGastroenteropancreatico Tumors
National Cancer Institute (NCI)56 enrolled1 locationNCT04086485